
    
      The main purpose of this study is to see whether the participant's disease responds favorably
      to the investigational drug, PF-04449913.

      Post treatment Phase: After coming off of active treatment study drug (PF-04449913),
      participants will be followed monthly for survival only. No other data will be captured
      during this time.
    
  